NPI: 1871545418 · BOISE, ID 83706 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/16/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/16/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 21,884 | $100K |
| 2019 | 19,136 | $101K |
| 2020 | 6,685 | $72K |
| 2021 | 813 | $27K |
| 2022 | 600 | $15K |
| 2024 | 540 | $9K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 15,441 | 1,047 | $259K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 15,431 | 601 | $50K |
| J1756 | Injection, iron sucrose, 1 mg | 3,108 | 593 | $6K |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,353 | 610 | $4K |
| 83970 | 671 | 424 | $3K | |
| A4657 | Syringe, with or without needle, each | 1,055 | 692 | $389.21 |
| 82728 | 333 | 201 | $209.25 | |
| 90674 | 41 | 27 | $152.28 | |
| 83550 | 335 | 202 | $142.90 | |
| 83540 | 335 | 202 | $112.87 | |
| G0008 | Administration of influenza virus vaccine | 31 | 25 | $56.12 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 112 | 75 | $25.84 |
| 85041 | 839 | 524 | $3.87 | |
| 85048 | 840 | 524 | $3.31 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 195 | 64 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 49 | 29 | $0.00 |
| 82607 | 56 | 36 | $0.00 | |
| 82746 | 49 | 33 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 384 | 50 | $0.00 |